Advertisement

Compensation Issues

The CEOs of the 14 biotech and pharmaceutical companies included in Standard & Poor's 500 that held their roles for the full 2015 fiscal year earned median compensation packages of $18.5 million for that year, according to USA Today analysis…

Wages across the country grew 3.4 percent year-over-year in July, according to Bloomberg Businessweek.

Advertisement

The median in-network deductible for employer-sponsored preferred provider organization health plans jumped from $1,000 in 2015 to $1,500 in 2016, or a 50 percent increase, according to new research from United Benefit Advisors.

Laval, Quebec, Canada-based Valeant Pharmaceuticals' new CFO Paul S. Herendeen will receive a base salary of $1 million and is eligible for an additional bonus as high as $2.4 million, according to The Wall Street Journal.

Advertisement